It built much of its capacity around the China boom peak and baked in a higher capital base than peers. This means returns are likely to lag the industry leaders who benefited from building ...

Discover key insights from Anglo American's Q4 2024 earnings call, including $1B cost savings, strategic portfolio moves, and future copper-focused growth.

CVRx , Inc. (NASDAQ:CVRX), a medical device company with a market capitalization of $382 million specializing in the development and commercialization of the Barostim therapy for heart failure and ...